alcohol use disorder
Information
- Disease name
- alcohol use disorder
- Disease ID
- DOID:1574
- Description
- "A substance abuse that involves the recurring use of alcoholic beverages despite negative consequences." [url:http\://en.wikipedia.org/wiki/Alcohol_abuse, url:https\://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/alcohol-use-disorders]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05326438 | Active, not recruiting | N/A | mHealth App for Changing Alcohol Use in Alaska Native American Indian People | August 10, 2022 | July 30, 2024 |
| NCT04267692 | Active, not recruiting | N/A | Harm Reduction Talking Circles for American Indians and Alaska Natives With Alcohol Use Disorders | September 28, 2020 | November 30, 2023 |
| NCT05317546 | Active, not recruiting | Phase 2 | Cannabidiol in Youth Alcohol Use Disorder | October 1, 2022 | July 2024 |
| NCT02652195 | Active, not recruiting | Phase 2 | Deciphering the Role of Oxytocin in Motivation: an fMRI Study. Part II | November 2016 | June 2024 |
| NCT04410913 | Active, not recruiting | Phase 2 | Pilot Trial of Visual Healing® in Psilocybin-assisted Therapy for Alcohol Use Disorder | February 18, 2021 | February 2023 |
| NCT03709043 | Active, not recruiting | Phase 2 | Addressing Heavy Alcohol Use Consumption With Kudzu | July 11, 2019 | June 30, 2024 |
| NCT04769986 | Active, not recruiting | N/A | Mobile Mindfulness for Alcohol Use and PTSD Among Veterans | January 1, 2023 | August 31, 2024 |
| NCT03995173 | Active, not recruiting | Phase 2 | Pilot rTMS for AUD+mTBI | March 21, 2019 | November 22, 2024 |
| NCT03467191 | Active, not recruiting | Early Phase 1 | Behavioral Alcohol Responses (BAR) Study | February 13, 2018 | July 31, 2024 |
| NCT05419128 | Active, not recruiting | N/A | Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19 | September 25, 2021 | June 30, 2024 |
| NCT05135767 | Active, not recruiting | N/A | Biobehavioral Pathways Underlying Alcohol Use and Health | February 28, 2022 | November 30, 2023 |
| NCT03660124 | Active, not recruiting | N/A | Deep Brain Stimulation (DBS) for the Treatment of Refractory Alcohol Use Disorder (AUD): Pilot Trial | May 25, 2018 | December 25, 2024 |
| NCT04098302 | Active, not recruiting | Phase 2/Phase 3 | Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of Efficacy | October 15, 2019 | May 30, 2025 |
| NCT03842670 | Active, not recruiting | N/A | Neurocognitive and Neurobehavioral Mechanisms of Change Following Psychological Treatment for Alcohol Use Disorder | November 14, 2018 | September 30, 2024 |
| NCT04067765 | Active, not recruiting | N/A | Using Neuroeconomics to Characterize State-Based Increases and Decreases in Alcohol Value | January 1, 2020 | December 31, 2024 |
| NCT04581499 | Active, not recruiting | N/A | Tech-Enabled CM for AUD at Scale | January 1, 2021 | April 2024 |
| NCT04565899 | Active, not recruiting | N/A | Improving Care for Unhealthy Alcohol Use in Primary Care | February 25, 2021 | September 30, 2025 |
| NCT04565288 | Active, not recruiting | Phase 2 | Enhancing the Effects of Adolescent Alcohol Treatment With Atomoxetine | May 6, 2021 | June 2023 |
| NCT03765476 | Active, not recruiting | N/A | Validation of a Training Program for Patients With Alcohol Use Disorder | July 1, 2018 | December 31, 2024 |
| NCT04535258 | Active, not recruiting | N/A | Blended Treatment for Alcohol Use Disorder | June 1, 2020 | December 31, 2026 |
| NCT02094196 | Completed | The Role of Dopaminergic and Glutamatergic Neurotransmission for Dysfunctional Learning in Alcohol Use Disorders | December 2012 | December 2018 | |
| NCT06105138 | Completed | N/A | Cannabidiol Effects on Blood Alcohol Level and Intoxication | March 9, 2021 | March 3, 2022 |
| NCT02135237 | Completed | N/A | Contingency Management for Alcohol Use Disorders | January 2014 | June 2019 |
| NCT02143037 | Completed | N/A | CM Treatment for Alcohol Dependence Using New Technology | May 2013 | March 2018 |
| NCT02161718 | Completed | Phase 2 | A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder | May 2014 | February 1, 2017 |
| NCT02168400 | Completed | N/A | Clinical Intervention in Alcohol Use Disorder | July 7, 2016 | November 17, 2022 |
| NCT02185131 | Completed | Phase 2 | Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD. | September 2013 | July 2016 |
| NCT02188043 | Completed | N/A | Project Relay Model for Recruiting Alcohol Dependent Patients in General Hospitals | November 2013 | June 2017 |
| NCT02210195 | Completed | Phase 2 | Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence | September 4, 2014 | December 19, 2016 |
| NCT05845398 | Completed | Phase 1 | Phase 1b Study of DCR-AUD in Healthy Volunteers | January 29, 2023 | August 22, 2023 |
| NCT02252536 | Completed | Phase 2 | HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder | June 2015 | March 2017 |
| NCT02322047 | Completed | Phase 2 | Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders | March 3, 2015 | October 10, 2018 |
| NCT02349477 | Completed | Phase 2 | Gabapentin for Alcohol Relapse Prevention | November 2014 | August 27, 2018 |
| NCT02354703 | Completed | Phase 2 | Pharmacogenetic Study of Ondansetron in Alcohol Use Disorder | August 2015 | March 31, 2020 |
| NCT05812469 | Completed | N/A | A Psychoeducational Intervention for Brain Awareness, Metacognition, Self-efficacy and Treatment Motivation | April 1, 2021 | March 1, 2023 |
| NCT02377726 | Completed | N/A | Anonymous Treatment on the Internet for Alcohol Dependence: A Randomised, Controlled Trial | April 1, 2015 | November 30, 2019 |
| NCT02445339 | Completed | Phase 4 | Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users | July 2015 | February 8, 2019 |
| NCT02461927 | Completed | Phase 1/Phase 2 | Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder | January 1, 2015 | October 30, 2023 |
| NCT02478489 | Completed | Phase 4 | Alcohol Disorder hOsPital Treatment Trial | June 2016 | October 2020 |
| NCT02480062 | Completed | N/A | mWELLCARE:An Integrated mHealth System for the Prevention and Care of Chronic Disease | April 2016 | September 2017 |
| NCT02504931 | Completed | Phase 4 | Serotonin Selective Reuptake Inhibitor Treatment of Dual Diagnosis Post-traumatic Stress Disorder and Alcohol Problems | April 2011 | December 2016 |
| NCT02511886 | Completed | Phase 2 | A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder | September 2015 | January 2016 |
| NCT02582905 | Completed | Phase 4 | Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders | May 2016 | May 2023 |
| NCT05564559 | Completed | N/A | Multifamily Group Psychoeducation for SUD's in Turkey | October 10, 2022 | August 30, 2023 |
| NCT02598518 | Completed | N/A | Integrating Combined Therapies for Persons With Co-occurring Disorders | July 2015 | December 31, 2017 |
| NCT02599818 | Completed | N/A | Navigation Services to Avoid Rehospitalization (NavSTAR) | March 15, 2016 | May 14, 2019 |
| NCT02600832 | Completed | N/A | AABM to Decrease Problem Drinking and Impulsivity in Veterans With AUD: A Pilot Study | January 2016 | February 7, 2018 |
| NCT02615977 | Completed | N/A | Learning and Relapse Risk in Alcohol Dependence (FP2) | April 2015 | June 2020 |
| NCT02646449 | Completed | Phase 2 | Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial | June 2015 | December 2016 |
| NCT02664727 | Completed | N/A | Effects of Acute Exercise on Various Parameters in Individuals With Alcohol Use Disorders | January 2014 | June 2014 |
| NCT02664766 | Completed | N/A | Effects of Long-term Exercise on Various Parameters in Heavy Drinkers | January 2014 | June 2015 |
| NCT02675777 | Completed | N/A | Sustaining Patient-centered Alcohol-related Care | February 2016 | February 2019 |
| NCT02698215 | Completed | Phase 2 | Combining Varenicline and Naltrexone for Smoking Cessation | May 2016 | December 2019 |
| NCT02735577 | Completed | Phase 4 | Neural Mechanisms of Disulfiram Effects | March 2016 | October 16, 2020 |
| NCT02742246 | Completed | N/A | Efficacy and Mechanisms of CBT4CBT for Alcohol Use Disorders | February 14, 2017 | December 31, 2021 |
| NCT02742532 | Completed | Phase 2 | Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress | April 20, 2017 | July 1, 2019 |
| NCT05563740 | Completed | N/A | Psychosocial Intervention For Domiciliary Alcohol Detoxification | January 1, 2020 | December 31, 2020 |
| NCT02774343 | Completed | Phase 1/Phase 2 | PPARγ Agonist Treatment for Cocaine Dependence | August 2012 | June 2015 |
| NCT02877849 | Completed | Brain Functional Connectivity in Alcohol Use Disorder | February 9, 2017 | October 31, 2019 | |
| NCT02881983 | Completed | Study of Mechanisms of Emotion Regulation in Alcohol-abstinent Patients | April 2014 | April 2017 | |
| NCT02884908 | Completed | Phase 3 | Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD | July 7, 2017 | January 19, 2022 |
| NCT02888002 | Completed | N/A | Internet-based vs Face-to-face Treatment for Alcohol Dependence | December 1, 2015 | March 30, 2020 |
| NCT02900352 | Completed | Phase 3 | Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action | October 2016 | April 22, 2021 |
| NCT02929979 | Completed | N/A | Cognitive Remediation for Alcohol Use Disorder and Posttraumatic Stress Disorder | January 1, 2015 | July 21, 2019 |
| NCT02949934 | Completed | Phase 2 | Effects of Cortical Dopamine Regulation on Drinking, Craving, and Cognitive Control | May 1, 2016 | April 13, 2021 |
| NCT02989662 | Completed | Phase 1/Phase 2 | INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers | September 26, 2017 | January 31, 2024 |
| NCT02994043 | Completed | N/A | Alcohol, Inflammation, and Mindfulness Study (AIM) | November 9, 2016 | February 17, 2021 |
| NCT05545644 | Completed | N/A | Brief Family-involved Treatment for Alcohol Use Disorder | April 1, 2015 | May 30, 2019 |
| NCT03034408 | Completed | Phase 2 | Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects | July 1, 2016 | December 17, 2018 |
| NCT03035708 | Completed | Phase 1/Phase 2 | Human Laboratory Study of Varenicline for Alcohol Use Disorder | May 1, 2017 | July 7, 2018 |
| NCT03037060 | Completed | N/A | Exploring Regulation and Function of Dopamine D3 Receptors in Alcohol Use Disorders: A [11C]-(+)-PHNO Study | December 2016 | August 2020 |
| NCT05522751 | Completed | N/A | Deep Brain Stimulation for Alcohol Use Disorder | January 10, 2023 | May 20, 2024 |
| NCT03056872 | Completed | Stress Reactivity as a Determinant in Co-occurring Alcohol Use and Anxiety Disorder: Diagnosis and Alcohol Use Outcomes | October 5, 2018 | May 12, 2023 | |
| NCT05520775 | Completed | Phase 2 | Semaglutide for Alcohol Use Disorder | September 2, 2022 | April 19, 2024 |
| NCT03099590 | Completed | Phase 2 | Alkontrol-herbal Effects on Alcohol Drinking | January 1, 2018 | July 1, 2020 |
| NCT03137654 | Completed | N/A | Sex Differences, Cognitive Training & Emotion Processing | August 16, 2017 | February 8, 2021 |
| NCT05520190 | Completed | N/A | Acceptability and Feasibility of Cognitive Behavioral Therapy for Treatment-Seeking (CBT-TS) With Deaf Individuals | April 3, 2023 | February 9, 2024 |
| NCT03175549 | Completed | Phase 2 | Medication Development in Alcoholism: Apremilast Versus Placebo | November 1, 2017 | April 1, 2020 |
| NCT05484258 | Completed | N/A | Loneliness and Health Outcomes in the High Need Population | August 15, 2022 | September 1, 2023 |
| NCT03200028 | Completed | N/A | CCTAP: Cognitive Control Training for Treatment of AUD-PTSD | April 1, 2018 | February 28, 2019 |
| NCT03205423 | Completed | Phase 2 | Medication Development for Opioid and Alcohol Abuse | August 1, 2017 | December 30, 2021 |
| NCT03216954 | Completed | Early Phase 1 | Influence of n-Acetylcysteine Maintenance on Alcohol Effects | September 15, 2017 | April 23, 2020 |
| NCT03220776 | Completed | Phase 2 | Imaging GABAergic/Glutamatergic Drugs in Bipolar Alcoholics Alcoholics | August 7, 2017 | November 21, 2022 |
| NCT03226743 | Completed | N/A | Collaborative and Stepped Care in Mental Health (COMET) | July 12, 2018 | October 7, 2022 |
| NCT05458609 | Completed | Phase 3 | Lemborexant Augmentation of Naltrexone for Alcohol Craving and Sleep | February 9, 2023 | January 30, 2024 |
| NCT05393544 | Completed | N/A | Digitally Assisted Recovery Coach | November 1, 2021 | May 15, 2022 |
| NCT03248167 | Completed | Phase 1/Phase 2 | Cannabidiol as a Treatment for AUD Comorbid With PTSD | September 16, 2019 | April 20, 2022 |
| NCT03252756 | Completed | Phase 1/Phase 2 | Effects of Cannabidiol in Alcohol Use Disorder | September 1, 2019 | March 16, 2022 |
| NCT03256253 | Completed | Phase 2 | Pregabalin as Treatment for Alcohol Use Disorder | February 15, 2018 | May 31, 2020 |
| NCT03258632 | Completed | N/A | Improving Outcomes Among Medical/Surgical Inpatients With Alcohol Use Disorders | September 1, 2018 | May 31, 2022 |
| NCT05357586 | Completed | N/A | The Pitt Center for Emergency Responder Wellness | March 29, 2022 | December 31, 2023 |
| NCT03271528 | Completed | Phase 1 | Lacosamide Effects on Alcohol Self Administration and Craving in Heavy Drinkers | April 15, 2018 | August 31, 2020 |
| NCT03276520 | Completed | N/A | Randomized Diagnostic Trial Comparing Ethylglucuronide and Ethanol | December 14, 2016 | July 31, 2017 |
| NCT05325788 | Completed | N/A | Developing e-Covery, an App-based Intervention to Support Individuals With Co-occurring Problem Alcohol and Opioid Use | November 4, 2022 | November 7, 2023 |
| NCT03299205 | Completed | N/A | Alcohol & Metabolic Comorbidities in PLWHA: Evidence Driven Interventions | November 20, 2017 | September 15, 2023 |
| NCT03300232 | Completed | N/A | Adapting an Effective CBT for Comorbidity to a Computer-Delivered Format | April 16, 2018 | July 26, 2021 |
| NCT03314454 | Completed | Phase 4 | Alcohol Use and Mental Health - Pilot Test of Video-assisted Drinking Topography | October 12, 2017 | June 1, 2023 |
| NCT03338933 | Completed | Neurobiology of Alcohol and Nicotine Co-Addiction | October 1, 2017 | December 29, 2023 | |
| NCT03339674 | Completed | N/A | Addiction Risk: Psychoeducational Intervention to Change Risk Perception Among Alcohol Patients in Residential Treatment | November 1, 2017 | December 31, 2019 |
| NCT05226130 | Completed | Phase 1 | Non-invasive Vagal Nerve Stimulation in Alcohol Use Disorder | May 2, 2022 | May 1, 2024 |
| NCT05187364 | Completed | N/A | BioWare for AUD and PTSD | May 5, 2022 | February 20, 2023 |
| NCT05155176 | Completed | Novel Real-world Methods in Social Drinkers and AUD | May 1, 2022 | December 31, 2023 | |
| NCT03406039 | Completed | N/A | Testing the Efficacy of an Online Integrated Treatment for Comorbid Alcohol Misuse and Emotional Problems | September 4, 2018 | March 17, 2020 |
| NCT03418623 | Completed | Phase 2 | Effect of GET73 on MRS Measures of Central Glutamate and GABA in Individuals With Alcohol Use Disorder | March 8, 2018 | March 13, 2020 |
| NCT03424681 | Completed | Phase 2 | Modafinil for the Treatment of Alcohol Use Disorders | December 11, 2017 | August 31, 2018 |
| NCT03424824 | Completed | Phase 2 | Randomized Clinical Trial Evaluating BP1.3656 Versus Placebo For Alcohol Use Disorder Treatment | January 9, 2018 | November 24, 2021 |
| NCT03428490 | Completed | N/A | Treatment for Comorbid Social Anxiety and Alcohol Use Disorders. | March 15, 2018 | April 30, 2021 |
| NCT03438539 | Completed | N/A | Brief Online Interventions for Alcohol Use | February 22, 2018 | July 27, 2018 |
| NCT03447054 | Completed | N/A | Severe Alcohol-use Disorder: a tDCS and Response Inhibition Training Intervention | January 1, 2018 | September 1, 2020 |
| NCT03448016 | Completed | Early Phase 1 | [C-11]NOP-1A and Alcohol Use Disorder | May 27, 2016 | March 30, 2021 |
| NCT03449095 | Completed | N/A | Understanding Alcohol Reward in Social Context | November 4, 2017 | July 5, 2023 |
| NCT03457077 | Completed | N/A | Neural and Mobile Assessment OF Behavior Change Among Problem Drinkers | February 27, 2018 | December 31, 2022 |
| NCT03474588 | Completed | N/A | CBT4CBT With Spanish Alcohol Users | August 6, 2019 | August 16, 2023 |
| NCT03489850 | Completed | Phase 2 | Ibudilast and Withdrawal-Related Dysphoria | July 16, 2018 | March 31, 2020 |
| NCT03493958 | Completed | N/A | RCT of Web-Based Behavioral Sleep Intervention for Individuals With Alcohol Use Disorder | March 5, 2019 | November 30, 2022 |
| NCT03507075 | Completed | Phase 1/Phase 2 | Remote Alcohol Monitoring to Facilitate Abstinence Reinforcement: Feasibility | November 15, 2014 | January 5, 2017 |
| NCT03517878 | Completed | Evaluation of a Home-based Community Health Worker Program in Rural Eastern Cape, South Africa | August 11, 2014 | June 1, 2018 | |
| NCT03524599 | Completed | N/A | Scale-up of Prevention and Management of Alcohol Use Disorders and Comorbid Depression in Latin America | September 12, 2018 | June 30, 2021 |
| NCT03530384 | Completed | N/A | Training Inhibition in Alcohol Use Disorder | February 25, 2019 | April 26, 2023 |
| NCT05143073 | Completed | N/A | Understanding Genetic Risk for Alcohol Use Disorder | November 15, 2021 | December 13, 2021 |
| NCT03573167 | Completed | N/A | Mobile Phone-Based Motivational Interviewing in Kenya | September 30, 2014 | December 31, 2015 |
| NCT03575403 | Completed | Phase 1 | Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate) | September 1, 2018 | March 15, 2023 |
| NCT03583788 | Completed | N/A | Effect of Hypnotherapy in Alcohol Use Disorder Compared to Motivational Interviewing. | February 1, 2016 | February 7, 2018 |
| NCT03589274 | Completed | N/A | Testing CBT Models and Change Mechanisms for Alcohol Dependent Women | June 1, 2010 | April 28, 2014 |
| NCT03594435 | Completed | Phase 2 | Ibudilast for the Treatment of Alcohol Use Disorder | October 1, 2018 | April 19, 2023 |
| NCT00167323 | Completed | N/A | Early Recovery Adherence Therapy for Bipolar Alcoholics | July 2003 | July 2007 |
| NCT03610633 | Completed | Phase 2 | Oxytocin and Stress Response in Alcohol Use Disorder | March 2016 | September 2018 |
| NCT03615222 | Completed | The Impact of Modifiable Psychosocial Factors on Veterans' Long-term Trajectories of Functioning and Quality of Life: Promoting Recovery by Targeting Mindfulness and Psychological Flexibility | October 1, 2018 | September 30, 2023 | |
| NCT05096117 | Completed | Phase 2 | Human Laboratory Study of ASP8062 for Alcohol Use Disorder | December 13, 2021 | March 22, 2023 |
| NCT05094440 | Completed | N/A | A Dialectical Behavioral Therapy Digital Health Solution for Outpatients Seeking Support for Substance Use | November 8, 2021 | May 31, 2023 |
| NCT03652675 | Completed | N/A | Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV | November 1, 2018 | June 8, 2020 |
| NCT03658330 | Completed | Phase 2 | Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder | May 2016 | June 2018 |
| NCT03661853 | Completed | N/A | Effect of CBT Microinterventions on Mechanisms of Behavior Change Among Adults With AUD | August 8, 2018 | July 26, 2019 |
| NCT03662737 | Completed | VRT as a Biomarker of Cerebellar Dysfunction in Chronic Cannabis Use | September 1, 2019 | December 31, 2021 | |
| NCT05093296 | Completed | Phase 2/Phase 3 | Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder | December 2, 2021 | September 27, 2023 |
| NCT03684798 | Completed | N/A | Mental Contrasting With Implementation Intentions for Alcohol Use Disorders | August 14, 2017 | March 4, 2019 |
| NCT03696888 | Completed | N/A | Skills-training for Reducing Risky Alcohol Use in App Form | December 7, 2018 | August 15, 2020 |
| NCT03701204 | Completed | N/A | Contingency Management for Alcohol Use Disorder | October 8, 2018 | August 21, 2019 |
| NCT03707951 | Completed | Phase 2 | N-Acetylcysteine for Adolescent Alcohol Use Disorder | February 27, 2019 | February 26, 2024 |
| NCT05048758 | Completed | Adverse Childhood Experiences in Alcohol Use Disorder | November 22, 2021 | January 17, 2024 | |
| NCT03732248 | Completed | Phase 1 | Altering Memories That Increase Risk of Relapse in Alcohol Use Disorders | July 12, 2018 | January 20, 2020 |
| NCT03746366 | Completed | Early Phase 1 | [C-11]PiB PET Imaging in Alcohol Use Disorders | December 1, 2018 | July 1, 2020 |
| NCT03746808 | Completed | N/A | Development and Testing of a Just-in-Time Adaptive Smart Phone Intervention to Reduce Drinking Among Homeless Adults | February 14, 2019 | May 31, 2022 |
| NCT04973202 | Completed | Portrayal of Hospital Alcohol Detoxification in France | May 1, 2021 | August 30, 2021 | |
| NCT03758274 | Completed | N/A | Talk Therapy by Phone to Promote Treatment for Alcohol Problems | March 1, 2019 | July 21, 2022 |
| NCT03786276 | Completed | N/A | Virtual Reality- Working Memory Retraining | February 1, 2019 | March 31, 2020 |
| NCT03806491 | Completed | N/A | CBT-I on Alcohol Treatment Outcomes Among Veterans | July 15, 2019 | July 31, 2022 |
| NCT03807544 | Completed | N/A | Treatment Parameters for the Empower Neuromodulation System (ENS) | January 15, 2019 | March 13, 2019 |
| NCT04964687 | Completed | Impact of Integrating an Addiction Team on Post Liver Transplantation Survival for Alcohol-related Liver Disease and Its Complications. | October 1, 2019 | May 30, 2021 | |
| NCT03810924 | Completed | N/A | Stress-related Predictor Profiles in Human Addiction | July 1, 2019 | July 8, 2023 |
| NCT03810950 | Completed | N/A | Psychobiology of Stress and Alcohol Craving | January 1, 2019 | December 31, 2019 |
| NCT03818191 | Completed | Phase 4 | Pharmacogenomics and Pharmacometabolomics of Acamprosate Treatment Outcome | July 15, 2019 | November 4, 2023 |
| NCT03818971 | Completed | N/A | Study of Retinal Function Using Electroretinogram in Regular Alcohol Users | May 13, 2019 | March 22, 2021 |
| NCT03823599 | Completed | N/A | Alcohol Brief Intervention Plus Personalized Mobile Chat-based Intervention to Reduce Alcohol Misuse in an Emergency Department | February 1, 2019 | May 30, 2019 |
| NCT04893044 | Completed | N/A | Alcohol Misuse Intervention in Active Duty US Navy Personnel | August 16, 2019 | October 10, 2019 |
| NCT03829761 | Completed | N/A | Cerebellar Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Alcohol Use Disorder | February 20, 2019 | September 7, 2023 |
| NCT04873453 | Completed | Phase 2 | CBD for the Treatment of Alcohol Use Disorder | August 30, 2021 | May 31, 2023 |
| NCT03845985 | Completed | N/A | Piloting "Signs of Safety": A Deaf-Accessible Therapy Toolkit for Alcohol Use Disorder and Trauma | June 3, 2019 | July 31, 2022 |
| NCT03846505 | Completed | Phase 2 | Oxytocin to Enhance Alcohol Behavioral Couple Therapy (ABCT) | May 16, 2019 | January 31, 2024 |
| NCT04858061 | Completed | N/A | "ALCO-VR": Virtual Reality Cue Exposure Therapy for the Treatment of Alcohol Use Disorder | September 15, 2018 | June 15, 2021 |
| NCT04817410 | Completed | Phase 1 | ED Initiated Oral Naltrexone for AUD | September 28, 2021 | November 2, 2023 |
| NCT03864146 | Completed | N/A | Pioglitazone for the Treatment of Alcohol Use Disorder | July 17, 2019 | May 8, 2024 |
| NCT04811729 | Completed | N/A | Effectiveness of an Intervention in Patients With Excessive Alcohol Consumption | February 18, 2022 | July 30, 2023 |
| NCT03872128 | Completed | Phase 1 | The Role of Neuroactive Steroids in Stress, Alcohol Craving and Alcohol Use in Alcohol Use Disorders | September 27, 2018 | August 1, 2023 |
| NCT04727086 | Completed | Phase 2 | Role of BP1.3656 on Alcohol Responses | February 1, 2021 | August 31, 2022 |
| NCT04725552 | Completed | N/A | Identifying and Managing Alcohol-related Health Problems in General Practice | October 1, 2020 | December 31, 2022 |
| NCT03896516 | Completed | Phase 1/Phase 2 | Manipulating Ghrelin Signaling Via GOAT Inhibition in Alcohol Use Disorder | June 22, 2021 | December 4, 2023 |
| NCT04656925 | Completed | N/A | Automated Reinforcement Management System (ARMS) | March 29, 2021 | December 8, 2021 |
| NCT03897348 | Completed | Phase 2 | Pilot Human Lab Study of Lacosamide in Alcohol Use Disorder (AUD) | September 17, 2018 | June 12, 2019 |
| NCT03898323 | Completed | N/A | Pilot Human Laboratory Study of Alcohol Approach Bias Modification (AABM) for Alcohol Use Disorder (AUD) | February 1, 2019 | January 31, 2020 |
| NCT04611854 | Completed | N/A | Internet-delivered Therapy for Alcohol Misuse: Investigating Patient Preference for Self-guided or Guided Treatment | November 1, 2020 | August 19, 2022 |
| NCT03902366 | Completed | HCV and Co-morbid Alcohol Use Disorders: A Translational Investigation of Antiviral Therapy Outcomes on CNS Function | May 16, 2019 | December 29, 2023 | |
| NCT04564807 | Completed | N/A | Testing an Online Insomnia Intervention | September 25, 2020 | May 31, 2022 |
| NCT04249882 | Completed | Phase 2 | A Novel Human Lab Model for Screening AUD Medications | January 28, 2020 | June 28, 2022 |
| NCT04248023 | Completed | N/A | Screening and Management of Unhealthy Alcohol Use in Primary Care | July 15, 2020 | May 31, 2023 |
| NCT00360594 | Completed | Phase 2 | Acamprosate Initiated During Alcohol Detoxification | October 2006 | November 2007 |
| NCT00369746 | Completed | STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse | September 2006 | February 2009 | |
| NCT00561041 | Completed | Phase 2 | Aftercare for Adolescents Treated for Alcohol Abuse and Dependence | November 2005 | November 2006 |
| NCT01037868 | Completed | N/A | Usefulness of Supportive Text Messages in the Treatment of Depressed Alcoholics | September 2009 | January 2012 |
| NCT01274741 | Completed | N/A | Present- Versus Past-focused Therapy for PTSD and Substance Use Disorder | January 2011 | March 2015 |
| NCT01377168 | Completed | Phase 4 | Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder | May 2014 | June 2017 |
| NCT01400581 | Completed | N/A | Considering Healthier Drinking Options in Collaborative Care | November 2011 | December 2015 |
| NCT00145678 | Completed | Phase 2 | Psychodynamic Therapy For Co-occurring Borderline Personality Disorder and Alcohol Use Disorder | June 2004 | May 2010 |
| NCT01442753 | Completed | N/A | Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth | September 2011 | January 2015 |
| NCT01908062 | Completed | Phase 3 | Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study | June 2014 | March 2015 |
| NCT01916941 | Completed | N/A | Neural Mechanisms of Change During the Treatment of Alcohol Use Disorders With Prazosin | September 2013 | September 2017 |
| NCT01932801 | Completed | Phase 2 | Harm Reduction With Pharmacotherapy (HaRP) | August 1, 2013 | June 30, 2019 |
| NCT02016378 | Completed | Phase 3 | EEG/Event-related Brain Potential Risk Markers as Predictors and Outcomes of SUD Treatment in Adolescents | January 2014 | December 2022 |
| NCT02026011 | Completed | Phase 2 | Naltrexone for Individuals of East Asian Descent | December 2013 | September 2016 |
| NCT02030288 | Completed | N/A | Relational Agent for Alcohol Screening and Treatment | February 19, 2015 | October 23, 2018 |
| NCT02046200 | Completed | Phase 1/Phase 2 | Development of Ivermectin for Alcohol Use Disorders | February 2014 | March 2015 |
| NCT02060162 | Completed | Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa | October 2013 | January 1, 2021 | |
| NCT02082678 | Completed | Phase 4 | Ondansetron for Bipolar Disorder and Alcohol Use Disorders | February 2014 | May 2018 |
| NCT04284813 | Completed | N/A | Families With Substance Use and Psychosis: A Pilot Study | September 24, 2020 | July 7, 2022 |
| NCT04278365 | Completed | N/A | Affective Modulation of Positivity for Alcohol Use Disorder | October 16, 2019 | June 19, 2020 |
| NCT04167306 | Completed | Phase 2 | Varenicline and Bupropion for Alcohol Use Disorder | March 4, 2019 | December 15, 2022 |
| NCT04182022 | Completed | N/A | Financially Sustainable Remote Treatment for Alcohol Abuse: Feasibility | December 1, 2016 | July 10, 2019 |
| NCT04278352 | Completed | N/A | Mindfulness-Based Relapse Prevention for Opioid and Alcohol Use Disorders | July 1, 2020 | August 1, 2023 |
| NCT04203966 | Completed | Mental Health and Well-being of People Who Seek Help From Their Member of Parliament | September 24, 2018 | September 18, 2019 | |
| NCT04218357 | Completed | Phase 1 | Probenecid as Medication for Alcohol Use Disorder | December 2, 2020 | May 20, 2023 |
| NCT04223154 | Completed | N/A | Effect of Theta Burst Stimulation on Alcohol Cue Reactivity | August 26, 2020 | April 16, 2021 |
| NCT03954054 | Completed | Therapeutic Education for Harm Reduction in People With Alcohol Use Disorder | October 28, 2019 | July 31, 2021 | |
| NCT04466215 | Completed | Phase 2 | Medication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo | April 15, 2021 | June 7, 2022 |
| NCT04460027 | Completed | Phase 1 | W-SUDs for COVID-19 | June 22, 2020 | November 30, 2020 |
| NCT03971097 | Completed | N/A | The Effect of Self-Forgiveness on Self-Stigma in Addiction. | August 1, 2019 | December 31, 2019 |
| NCT00246441 | Completed | Phase 4 | Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism | March 2002 | February 2008 |
| NCT03983317 | Completed | N/A | Pilot Evaluation of the Empower Neuromodulation System in AUD Patients | May 20, 2019 | March 26, 2020 |
| NCT03988478 | Completed | N/A | Inpatient Alcohol Detox & Psychotherapy | January 1, 2017 | September 25, 2018 |
| NCT03991650 | Completed | Monitoring Telemedicine Platform in Patients With Anxiety Symptoms and Alcohol Use Disorder | February 1, 2019 | November 5, 2019 | |
| NCT03996876 | Completed | N/A | Resolving Psychological Stress | January 9, 2018 | August 16, 2019 |
| NCT03998397 | Completed | N/A | Self-estimates and Objective Blood Alcohol Concentration in Emergency Department | June 18, 2019 | June 18, 2020 |
| NCT04009707 | Completed | Comparison of 2 Tests to Diagnose Cognitive Dysfunctions in Alcohol Disease | November 2, 2017 | November 2, 2018 | |
| NCT04015869 | Completed | Phase 1 | Effect of Allopregnanolone on Stress-induced Craving | July 1, 2019 | September 1, 2023 |
| NCT04018560 | Completed | N/A | Intensive Referral to Al-Anon: Benefits to Concerned Others and Their Drinkers | March 7, 2017 | February 28, 2021 |
| NCT04038021 | Completed | N/A | Phosphatidylethanol-Based Contingency Management for Housing | January 13, 2020 | October 27, 2022 |
| NCT04447794 | Completed | N/A | Step Away: Comparing a Chatbot-delivered Alcohol Intervention With a Smartphone App | June 2, 2020 | January 6, 2021 |
| NCT04059549 | Completed | N/A | Building and Pilot Testing a Couples-based Smartphone Systems to Address Alcohol Use Disorder | November 17, 2020 | September 29, 2021 |
| NCT04412824 | Completed | Early Phase 1 | Multimodal Neuroimaging of Alcohol Cues, Cortisol Response, and Compulsive Motivation | May 22, 2020 | December 31, 2021 |
| NCT04380116 | Completed | N/A | Preliminary Effectiveness of Remotely Monitored Blood Alcohol Concentration Device as Treatment Modality | June 29, 2020 | May 1, 2022 |
| NCT04071119 | Completed | Phase 1 | Alcohol and Cigarette Craving During Oxytocin Treatment | November 9, 2020 | April 2, 2024 |
| NCT04318639 | Completed | Phase 2/Phase 3 | The Combination of Donepezil and Cognitive Training for Treating Alcohol Use Disorder | August 17, 2018 | December 31, 2019 |
| NCT04317989 | Completed | N/A | STUN (STop UNhealthy) Alcohol Use Now! Implementing Evidence-Based Services for Unhealthy Alcohol Use in Primary Care | January 22, 2020 | October 31, 2023 |
| NCT04101227 | Completed | Phase 3 | Study to Evaluate AD04 in Adults With Alcohol Use Disorder (AUD) and Selected Serotonin Transporter Polymorphisms | February 1, 2020 | March 18, 2022 |
| NCT04106739 | Completed | N/A | A Study of New Treatment for Excessive Alcohol Users by Electric Stimulation of Nerves Around Ear | October 20, 2019 | December 27, 2021 |
| NCT04108104 | Completed | Phase 2 | Clinical Outcome of a Patented Pharmaceutical Composition (KT-110) to Treat Alcohol Use Disorder While Avoiding Major Side Effects | November 30, 2019 | January 31, 2022 |
| NCT04314648 | Completed | N/A | Substance Use Treatment and Recovery Team (START) | December 4, 2020 | December 31, 2022 |
| NCT04128228 | Completed | N/A | Neurobiological Responses in Alcoholism and Early Trauma | October 3, 2019 | September 8, 2023 |
| NCT04310423 | Completed | Phase 2 | An Inflammatory Challenge Using Endotoxin | October 19, 2021 | November 14, 2023 |
| NCT04141501 | Completed | Phase 2 | Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients | June 8, 2020 | September 14, 2023 |
| NCT04303676 | Completed | N/A | Facilitating Alcohol Screening and Treatment (FAST) | May 26, 2020 | April 13, 2023 |
| NCT04155385 | Completed | N/A | Addiction Treatment Outcome Monitoring Study | October 4, 2019 | December 1, 2021 |
| NCT04286867 | Completed | Phase 1/Phase 2 | Examining Alcohol Consumption, Perceptions, and User Experience of Alcohol Moderation Strategies | February 5, 2020 | May 10, 2022 |
| NCT03942770 | Enrolling by invitation | N/A | Remote Alcohol Monitoring to Facilitate Abstinence From Alcohol: Exp 2 | July 15, 2019 | November 2024 |
| NCT05612061 | Enrolling by invitation | N/A | Indigenous Recovery Planning for American Indians | November 2, 2022 | February 2026 |
| NCT04946851 | Enrolling by invitation | Addictions Neuroclinical Assessment (ANA) | August 12, 2021 | December 31, 2031 | |
| NCT04356274 | Enrolling by invitation | N/A | Local Participatory Systems Dynamics to Increase Reach of Evidence Based Addiction and Mental Health Care | February 1, 2019 | August 31, 2024 |
| NCT06173973 | Enrolling by invitation | Phase 2/Phase 3 | Effects of Ketone Supplementation on Acute Alcohol Withdrawal | March 11, 2024 | December 2027 |
| NCT04244032 | Enrolling by invitation | N/A | Cognitive Enhancement Through Computerized Training | April 28, 2021 | September 30, 2024 |
| NCT05606900 | Enrolling by invitation | N/A | Eye Movements Desensitization and Reprocessing Intervention in Preventing Craving in Alcohol Use Disorder | October 1, 2022 | December 31, 2023 |
| NCT04128761 | Enrolling by invitation | N/A | Decreasing the Temporal Window in Individuals With Alcohol Use Disorder | September 21, 2023 | June 30, 2024 |
| NCT06457113 | Not yet recruiting | N/A | Emotional Attention Bias Modification and Targeted Memory Reactivation in Alcohol Use Disorder | June 30, 2024 | June 30, 2025 |
| NCT03595293 | Not yet recruiting | N/A | fNIRs-based Neurofeedback to Reduce Relapse in pOUD/AUD | January 1, 2026 | February 2028 |
| NCT03981185 | Not yet recruiting | N/A | aTBS for Treatment of Depression in AUD | December 1, 2024 | December 31, 2026 |
| NCT04447079 | Not yet recruiting | Assertive Community Treatment for Alcohol Misuse Disorder Patients Who Are High Utilizers of Emergency Department Services | August 2020 | August 2027 | |
| NCT05070793 | Not yet recruiting | N/A | Improving Alcohol Use Disorder Treatment for Gender Minority Populations | July 1, 2024 | July 2025 |
| NCT05159830 | Not yet recruiting | Phase 2 | Cannabidiol for Reducing Drinking in Alcohol Use Disorder | June 1, 2024 | December 31, 2024 |
| NCT05228418 | Not yet recruiting | Phase 4 | Bridging ED to Outpatient AUD Therapy With Naltrexone | March 2022 | July 2025 |
| NCT05355311 | Not yet recruiting | Phase 1 | Enhancing the Effects of Adolescent Alcohol Treatment With Acetyl-L-Carnitine | June 2023 | August 2024 |
| NCT05427734 | Not yet recruiting | N/A | Treating Drivers of Suicide Using Jaspr Health | September 15, 2023 | August 31, 2024 |
| NCT05505188 | Not yet recruiting | N/A | Predictive and Impact of Pain After 6 Months of Radiotherapy, in Head and Neck Cancer | September 1, 2022 | September 1, 2024 |
| NCT05576350 | Not yet recruiting | N/A | TRAC-ER Intervention to Reduce Risky Alcohol Use Among Sexual Minority Males and Transgender Individuals | July 2024 | May 2027 |
| NCT05621538 | Not yet recruiting | N/A | A Combined Neurofeedback-TMS Intervention for Alcohol Use Disorder | January 31, 2024 | March 31, 2026 |
| NCT05800899 | Not yet recruiting | N/A | Trial of a Culturally Informed Brief Intervention to Reduce Alcohol Related Health Disparities and Treatment Inequities Among Latinxs | May 1, 2023 | February 1, 2028 |
| NCT05821634 | Not yet recruiting | N/A | Digital Phenotyping of Anxiety and Anxiety-Related Alcohol Co-occurrence: Pilot Study | May 2024 | April 2027 |
| NCT05827159 | Not yet recruiting | Phase 3 | Emergency Department-Initiated Medications for Alcohol Use Disorder | June 1, 2024 | March 1, 2028 |
| NCT05828849 | Not yet recruiting | N/A | Mortality Reductions Based on AUD/Heavy Alcohol Use, HIV Risk, and Cardiovascular Risk | April 15, 2024 | July 2025 |
| NCT05830708 | Not yet recruiting | N/A | The Efficacy of Probiotics for the Treatment of Alcohol Use Disorder Among Adult Males | May 1, 2023 | April 30, 2026 |
| NCT05841823 | Not yet recruiting | N/A | Virtual Reality Exposure Therapy in the Treatment of Alcohol Use Disorder | June 1, 2023 | May 31, 2026 |
| NCT05870111 | Not yet recruiting | Phase 2 | Citicoline in Youth Alcohol Use Disorder | July 2024 | February 2029 |
| NCT05901610 | Not yet recruiting | N/A | Decision Making in Chronic Pain and Alcohol Use Disorder | July 1, 2024 | September 1, 2025 |
| NCT05913752 | Not yet recruiting | Phase 1/Phase 2 | A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects | April 1, 2024 | September 1, 2024 |
| NCT05943171 | Not yet recruiting | N/A | A Randomized Controlled Trial of Digital CBT to Treat Addiction: Digital RITch®CBT vs. Standard CBT | September 1, 2023 | August 31, 2024 |
| NCT05997212 | Not yet recruiting | N/A | Effect of Repetitive TMS on Executive Function in Alcohol Use Disorder | September 1, 2023 | November 1, 2026 |
| NCT06006143 | Not yet recruiting | N/A | Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2 | January 1, 2025 | December 31, 2025 |
| NCT06029296 | Not yet recruiting | Early Phase 1 | Diclofenac as a KMO Inhibitor | June 2024 | December 2024 |
| NCT06090422 | Not yet recruiting | Phase 1/Phase 2 | Ketamine for Combined Depression and Alcohol Use Disorder | January 1, 2024 | July 1, 2027 |
| NCT06093919 | Not yet recruiting | Study of Prevalence of Eating Disorder in Liver Transplant Patients | February 12, 2024 | December 30, 2024 | |
| NCT06147622 | Not yet recruiting | Phase 1 | A Study to Assess the Pharmacokinetic Profile of Prazosin and Cyproheptadine | April 2024 | June 2024 |
| NCT06163651 | Not yet recruiting | N/A | Evaluating a One-Year Version of the Parent-Child Assistance Program | September 2024 | September 30, 2026 |
| NCT06224127 | Not yet recruiting | Phase 1 | Treating Stress and Anxiety in Individuals With Alcohol Use Disorder (AUD) | July 15, 2024 | March 30, 2025 |
| NCT06244641 | Not yet recruiting | N/A | New Relapse Model in Psychiatry | February 2024 | February 2028 |
| NCT06256952 | Not yet recruiting | N/A | Effect of Social Isolation on the Role of Pavlovian Mechanisms for Control Over Alcohol Use | February 19, 2024 | June 30, 2027 |
| NCT06265506 | Not yet recruiting | N/A | Virtual Incentive Treatment for Alcohol | February 19, 2024 | April 4, 2028 |
| NCT06269627 | Not yet recruiting | Phase 4 | Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder | June 23, 2024 | December 31, 2026 |
| NCT06286449 | Not yet recruiting | N/A | Identification of Cellular and Molecular Mechanisms Involved in the Pathophysiology of Alcohol Use Disorder by Examination of Cerebrospinal Fluid | March 1, 2024 | December 31, 2026 |
| NCT06290778 | Not yet recruiting | N/A | Peer Delivered, Emotion Regulation-Focused Mental Health Prevention Training for Fire Fighter Trainees | March 2024 | August 2027 |
| NCT06305624 | Not yet recruiting | N/A | Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease | June 2024 | October 2027 |
| NCT06318026 | Not yet recruiting | N/A | Systematic Implementation of Patient-centered Care for Alcohol Use Trial: Beyond Referral to Treatment | July 2024 | February 2029 |
| NCT06319872 | Not yet recruiting | Phase 1 | The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration | April 15, 2024 | April 15, 2025 |
| NCT06320015 | Not yet recruiting | Emergency Medicine Peer Outreach Worker Engagement for Recovery | August 1, 2024 | September 2025 | |
| NCT06333288 | Not yet recruiting | N/A | Pilot Trial to Evaluate PROblem Solving Therapy and APPLE Watch for College Students | April 15, 2024 | March 30, 2025 |
| NCT06337721 | Not yet recruiting | N/A | Preventing Alcohol Use Disorders and Alcohol-Related Harms in Pacific Islander Young Adults | September 2024 | August 2028 |
| NCT06349083 | Not yet recruiting | Phase 2 | Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD | July 2024 | January 2029 |
| NCT06371404 | Not yet recruiting | Imaging Traumatic Stress and Alcohol Use Disorder With [18F]Bavarostat | June 1, 2024 | June 1, 2031 | |
| NCT06380985 | Not yet recruiting | N/A | Personalized Approach Bias Modification in Heavy Drinking Veterans With Mild to Moderate Traumatic Brain Injury | July 1, 2024 | December 31, 2027 |
| NCT06381609 | Not yet recruiting | N/A | Peer Support in Alcohol Dependence | October 1, 2024 | April 1, 2028 |
| NCT06395467 | Not yet recruiting | N/A | 12-Step Facilitation/MET/CBT (InTEGRA) vs. MET/CBT for Youth With Alcohol and Other Drug Use Disorder | June 1, 2024 | April 30, 2027 |
| NCT06399653 | Not yet recruiting | N/A | Non-invasive Vagal Nerve Stimulation as Novel Treatment to Improve Functional Outcomes in Veterans With Alcohol Use Disorder | July 1, 2024 | June 30, 2029 |
| NCT06405607 | Not yet recruiting | Phase 2 | Psilocybin vs Ketamine for Alcohol Use Disorder | June 2024 | June 2027 |
| NCT06415721 | Not yet recruiting | N/A | Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder | July 1, 2024 | January 1, 2026 |
| NCT06419647 | Not yet recruiting | N/A | Tracking Mood: The Effects of Daily Mood Tracking VAS on Alcohol Consumption in Adult Heavy Drinkers | May 2024 | December 2025 |
| NCT06444243 | Not yet recruiting | Phase 2 | Psilocybin-assisted Therapy for Alcohol Use Disorder | September 2024 | December 2025 |
| NCT03904498 | Recruiting | Phase 2 | COMT Inhibition Among Individuals With Comorbid AUD/ADHD | August 16, 2021 | March 1, 2025 |
| NCT05855031 | Recruiting | N/A | The Liver Care Trial | May 8, 2023 | May 1, 2027 |
| NCT05855668 | Recruiting | N/A | Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment | November 10, 2022 | December 2027 |
| NCT05861843 | Recruiting | Craving Assessment in Patients With Alcohol Use Disorder Using Virtual Reality Exposure | September 23, 2023 | June 2024 | |
| NCT06324435 | Recruiting | Phase 1 | Apremilast for Alcohol Use Disorder Treatment in Women and Men | May 8, 2024 | February 28, 2025 |
| NCT05884619 | Recruiting | N/A | Efficacy and Safety of Dual-target Deep Brain Stimulation for Treatment-resistant Alcohol Use Disorder | August 14, 2023 | December 30, 2024 |
| NCT05885594 | Recruiting | Early Phase 1 | Imaging Inflammation With Alcohol Use Disorder: an [18F]NOS Study | April 25, 2023 | March 15, 2027 |
| NCT05891587 | Recruiting | Phase 2 | Semaglutide Therapy for Alcohol Reduction - Tulsa | July 7, 2023 | December 2025 |
| NCT05892432 | Recruiting | Phase 2 | Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD) | January 11, 2024 | June 30, 2025 |
| NCT05893277 | Recruiting | N/A | Harmony: A Combined MI and BCT Intervention to Reduce Intimate Partner Violence and Alcohol Use in South India | October 12, 2023 | July 2027 |
| NCT05895643 | Recruiting | Phase 2 | Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity? | June 13, 2023 | March 2027 |
| NCT05896332 | Recruiting | Phase 1 | rTMS in Older Adults With MCI and AUD | November 1, 2023 | December 1, 2025 |
| NCT06326684 | Recruiting | Early Phase 1 | Suvorexant and Alcohol | June 7, 2024 | March 15, 2027 |
| NCT05902754 | Recruiting | N/A | Broccoli Extract Supplementation in Older Adults With Alcohol Use Disorder | January 23, 2024 | August 2024 |
| NCT05913518 | Recruiting | N/A | Neurofeedback Training of Metacognition in Subjects With Alcohol Use Disorder. Disorder Induces Neural Modifications: an Event-related Potentials Study | August 1, 2023 | June 1, 2025 |
| NCT06283446 | Recruiting | N/A | Enhancing Prospective Thinking in Early Recovery | December 20, 2023 | July 31, 2024 |
| NCT05929677 | Recruiting | Early Phase 1 | Impulsivity Domains and Subjective Response | April 1, 2024 | September 1, 2027 |
| NCT05937893 | Recruiting | N/A | Metabolism in the Human Brain Following Consumption of a Keto-ester in Alcohol Use Disorder (AUD) With Proton Magnetic Resonance Spectroscopic Imaging (MRSI) | August 14, 2023 | October 2024 |
| NCT05942521 | Recruiting | N/A | Effects of Subconscious Memory Extinction in Patients With Alcohol Dependence and Its Mechanism | July 20, 2023 | December 2024 |
| NCT06283472 | Recruiting | N/A | Enhancing Prospective Thinking in Early Recovery (BEAM) | June 1, 2024 | February 1, 2027 |
| NCT05943665 | Recruiting | Phase 2 | MDMA for AUD/PTSD Comorbidity | February 6, 2024 | January 30, 2025 |
| NCT05947539 | Recruiting | N/A | Improving HIV Care Engagement Among Ugandan Adolescent Girls and Young Women: The Kisoboka Mukwano Intervention | July 1, 2023 | August 2025 |
| NCT05948605 | Recruiting | N/A | EMPOWER AUD Pivotal Trial | December 1, 2023 | May 1, 2025 |
| NCT05957159 | Recruiting | Early Phase 1 | Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder | November 7, 2023 | November 1, 2028 |
| NCT05959434 | Recruiting | Phase 2 | Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and PTSD | April 1, 2024 | July 31, 2028 |
| NCT05970484 | Recruiting | N/A | Supporting Women in the UK Armed Forces Who Consume Alcohol at an Increased Risk: Refining the DrinksRation Platform | September 1, 2023 | August 31, 2024 |
| NCT05988632 | Recruiting | Phase 1/Phase 2 | Intranasal Insulin for Treatment of Alcohol Use Disorder | March 25, 2024 | March 30, 2025 |
| NCT05995769 | Recruiting | Phase 2 | Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder | March 20, 2024 | October 1, 2027 |
| NCT06456905 | Recruiting | N/A | Automated Reinforcement Management Systems, Phase II | June 7, 2024 | September 1, 2025 |
| NCT05999344 | Recruiting | N/A | Alcohol and Cannabis Concentrates Co-Administration | December 16, 2021 | August 1, 2024 |
| NCT06004830 | Recruiting | N/A | Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1 | November 6, 2023 | December 31, 2024 |
| NCT06005298 | Recruiting | N/A | Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention | October 1, 2023 | October 1, 2027 |
| NCT06426303 | Recruiting | Phase 4 | Sex Differences in Trauma, Inflammation and Brain Function and the Implications for Treatment Efficacy in Alcohol Use Disorder | June 1, 2024 | December 31, 2028 |
| NCT06015893 | Recruiting | Phase 2 | Semaglutide Therapy for Alcohol Reduction (STAR) | June 23, 2024 | December 31, 2030 |
| NCT06299787 | Recruiting | N/A | Cognitive Dysfunction in the Addictions Study - Project 4 (P4) | February 7, 2022 | July 1, 2025 |
| NCT06030154 | Recruiting | N/A | Amplification of Positivity for Alcohol Use | September 25, 2023 | July 2026 |
| NCT06060496 | Recruiting | N/A | Theta Burst Stimulation for Alcohol Use Disorder | October 1, 2023 | December 31, 2024 |
| NCT06063200 | Recruiting | Early Phase 1 | Methylphenidate and Response to Alcohol Cues | March 20, 2024 | June 2025 |
| NCT06074341 | Recruiting | N/A | TeleHealth Resources for IndiVidualizEd Goals (THRIVE) in Alcohol Recovery Study | September 13, 2023 | July 31, 2028 |
| NCT06084520 | Recruiting | Translation and Validation of the COMM and ASI-SR | December 1, 2023 | December 31, 2026 | |
| NCT06302413 | Recruiting | N/A | Enhancing Prospective Thinking in Early Recovery | February 15, 2024 | July 31, 2027 |
| NCT06304467 | Recruiting | N/A | CM for Patients With ALD After Liver Transplant | April 1, 2024 | March 1, 2026 |
| NCT02108054 | Recruiting | N/A | Behavioral and Functional Task Development, Implementation, and Testing | May 28, 2014 | December 31, 2025 |
| NCT06105853 | Recruiting | N/A | Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder | December 1, 2023 | June 30, 2027 |
| NCT04282915 | Recruiting | N/A | Reducing Stigma Among Healthcare Providers (RESHAPE-cRCT) | February 22, 2022 | December 2024 |
| NCT04154111 | Recruiting | N/A | Theta Burst Stimulation as a Tool to Decrease Drinking in Treatment-seeking Alcohol Users | May 26, 2020 | August 2025 |
| NCT04125238 | Recruiting | N/A | Increasing the Temporal Window in Individuals With Alcohol Use Disorder | November 13, 2020 | November 30, 2024 |
| NCT04084860 | Recruiting | Phase 2 | The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking | November 8, 2019 | August 31, 2024 |
| NCT04356261 | Recruiting | Phase 2 | Revolutionizing Normative Re-education | August 15, 2021 | May 30, 2024 |
| NCT04360018 | Recruiting | Phase 1 | Effect of Acute Alcohol Intoxication on Neural Processes During Decisions to Engage in HIV Risk Behaviors | March 18, 2021 | June 30, 2024 |
| NCT04066192 | Recruiting | Phase 2 | Brexpiprazole in Alcohol Use Disorder | October 30, 2020 | August 31, 2025 |
| NCT04393623 | Recruiting | N/A | Stress, Emotion Regulation, and Alcohol in Women Veterans | November 1, 2020 | September 30, 2024 |
| NCT04402619 | Recruiting | N/A | Online Cognitive Behavior Therapy for Comorbid Sleep Problems in Alcohol Use Disorder | April 13, 2020 | December 31, 2023 |
| NCT04064463 | Recruiting | N/A | Dual Reinforcement Contingency Management for Alcohol Use Disorders | January 22, 2020 | May 2025 |
| NCT04063384 | Recruiting | N/A | Acute Alcohol Response In Bipolar Disorder: a fMRI Study | July 22, 2019 | March 31, 2024 |
| NCT04426214 | Recruiting | N/A | Neuromodulation and Cognitive Training for Substance Use Disorders | July 16, 2021 | June 30, 2024 |
| NCT06118346 | Recruiting | N/A | A Female-Specific CBT Group for Veteran Women With Alcohol Use Disorder in VA Primary Care Settings | February 24, 2023 | January 30, 2026 |
| NCT04043442 | Recruiting | Phase 2 | rTMS Target Identification for Functional Disability in AUD+mTBI | January 1, 2019 | May 31, 2025 |
| NCT04457674 | Recruiting | N/A | Targeting Sleep Homeostasis to Improve Alcohol Use Disorder Treatment Outcomes (M-STAR Study) | November 15, 2020 | August 31, 2024 |
| NCT04463225 | Recruiting | N/A | The Network Study: Soldiers Connecting for Work and Health | March 30, 2021 | March 31, 2024 |
| NCT04488055 | Recruiting | N/A | Facilitating Use of the National Suicide Prevention Lifeline in Alcohol Patients (Reach Out) | October 15, 2020 | June 2025 |
| NCT04523922 | Recruiting | Phase 2 | Oxytocin to Enhance Integrated Treatment for AUD and PTSD | March 29, 2021 | January 1, 2026 |
| NCT04527185 | Recruiting | Phase 2 | Effect of Endotoxin on Alcohol Consumption | February 27, 2022 | October 31, 2024 |
| NCT04535011 | Recruiting | N/A | PRACT to Investigate Controlling Alcohol Related Harms in a Low-Income Setting; Emergency Department BIs in Tanzania | October 12, 2020 | May 1, 2025 |
| NCT04574167 | Recruiting | N/A | Effects of tDCS Paired With Cognitive Training on Brain Networks Associated With Alcohol Use Disorder in Veterans | January 1, 2020 | December 31, 2024 |
| NCT04580810 | Recruiting | N/A | Black Church Treatment Study | July 7, 2021 | October 31, 2026 |
| NCT04582695 | Recruiting | N/A | Early Intervention Following Sexual Assault | December 15, 2020 | July 31, 2025 |
| NCT04616781 | Recruiting | Phase 2/Phase 3 | Ketone Ester Intervention in Alcohol Use Disorder | April 5, 2021 | September 2025 |
| NCT04620759 | Recruiting | Phase 2 | Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder | April 14, 2021 | August 31, 2026 |
| NCT04647422 | Recruiting | N/A | Social Cognition and Executive Functions in Alcohol Use Disorders - Transverse Study | December 9, 2020 | May 9, 2024 |
| NCT04667520 | Recruiting | N/A | Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment | May 10, 2021 | June 30, 2026 |
| NCT04679142 | Recruiting | Baclocur® Post-Authorisation Safety Study in Real-life Settings in France | December 22, 2020 | November 2025 | |
| NCT04716036 | Recruiting | N/A | Familial Risk for Bipolar Disorder and Alcohol Sensitivity | May 13, 2021 | July 31, 2024 |
| NCT03883126 | Recruiting | N/A | Remote Alcohol Monitoring to Facilitate Abstinence From Alcohol: Exp 1 | June 16, 2020 | November 2024 |
| NCT03878316 | Recruiting | Phase 2 | Intranasal Oxytocin for the Treatment of Alcohol Use Disorder | May 5, 2022 | March 2024 |
| NCT04743024 | Recruiting | TREAT Child Alcohol Use Disorder (C-AUD) in Eastern Uganda | December 27, 2020 | July 31, 2025 | |
| NCT04748822 | Recruiting | N/A | Quality of Life in Patients With Alcohol Use Disorder | March 25, 2021 | September 30, 2023 |
| NCT04770025 | Recruiting | Phase 2 | A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol | September 1, 2020 | February 28, 2025 |
| NCT04770493 | Recruiting | Phase 2 | Enhancing the Effects of Alcohol Treatment With Lamotrigine | January 24, 2022 | October 2024 |
| NCT04771650 | Recruiting | N/A | A Hybrid Effectiveness Implementation Study of Latino/a Alcohol and Drug Users | March 25, 2022 | August 1, 2028 |
| NCT04788004 | Recruiting | Long-term Recovery: Longitudinal Study of Neuro-behavioral Markers of Recovery and Precipitants of Relapse | September 8, 2022 | February 1, 2026 | |
| NCT04831684 | Recruiting | Phase 1/Phase 2 | Novel mGluR5 Modulator Effects on Alcohol Drinking and MRI Outcomes | September 15, 2021 | April 22, 2026 |
| NCT03845205 | Recruiting | N/A | Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH | November 20, 2020 | January 2025 |
| NCT03827460 | Recruiting | Phase 1 | Sex Differences in the Response to Abstinence From Alcohol. | April 10, 2019 | March 31, 2026 |
| NCT04923256 | Recruiting | N/A | AAT-APP+: A Novel Brain-training App to Reduce Drinking | June 30, 2022 | March 1, 2023 |
| NCT04929288 | Recruiting | N/A | Neural and Hormonal Influences on Sex Differences in Risk for AUD | May 11, 2021 | June 30, 2025 |
| NCT03816527 | Recruiting | Selective Attention in Alcohol Use Disorder | January 1, 2019 | December 31, 2024 | |
| NCT03809286 | Recruiting | N/A | The Effect of rTMS to the Prefrontal Cortex in Alcohol Use Disorder | June 24, 2019 | December 30, 2024 |
| NCT04998916 | Recruiting | N/A | MPFC Theta Burst Stimulation as a Treatment Tool for Alcohol Use Disorder: Effects on Drinking and Incentive Salience | July 6, 2021 | December 31, 2026 |
| NCT05007470 | Recruiting | N/A | Alcoholic Liver Disease and the Gut Microbiome | January 31, 2022 | September 1, 2025 |
| NCT05028062 | Recruiting | Phase 4 | Naltrexone in AUD Reward Drinkers | March 7, 2022 | November 2026 |
| NCT05028998 | Recruiting | COVID-19-Related Opioid Treatment Policy Evaluation | September 15, 2021 | August 31, 2023 | |
| NCT05042102 | Recruiting | Phase 2 | Donepezil and Cognitive Training for Alcohol Use Disorder (AUD) | August 8, 2022 | May 31, 2026 |
| NCT03718104 | Recruiting | MOM NEST Study: Maternal Opioid Medication: Naltrexone Efficacy Study | December 1, 2018 | September 2024 | |
| NCT05062369 | Recruiting | N/A | Tdcs And cogNitive traininG cOmbined for AUD (TANGO) | March 3, 2022 | September 2025 |
| NCT06118580 | Recruiting | Phase 2 | Neural Correlates During Alcohol Intoxication | June 8, 2023 | August 31, 2026 |
| NCT05074030 | Recruiting | N/A | EMA/EMI for Psychiatrically Hospitalized Emerging Adults Who Drink to Cope | February 6, 2023 | March 31, 2025 |
| NCT03667846 | Recruiting | Phase 2 | Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD | October 16, 2019 | August 31, 2025 |
| NCT05107765 | Recruiting | Phase 1/Phase 2 | Effects of Pioglitazone on Stress Reactivity and Alcohol Craving | May 12, 2022 | August 1, 2024 |
| NCT05117255 | Recruiting | N/A | Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity | January 4, 2022 | March 1, 2026 |
| NCT06134128 | Recruiting | N/A | Compensatory Cognitive Training Via Telehealth for Veterans With Alcohol Use Disorders | October 2, 2023 | June 2025 |
| NCT05163301 | Recruiting | N/A | Alcohol Research in HIV: Relapse Prevention | March 27, 2023 | May 31, 2026 |
| NCT05178069 | Recruiting | Phase 2 | LGG Supplementation in Patients With AUD and ALD | June 1, 2022 | February 28, 2027 |
| NCT05191446 | Recruiting | N/A | Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use | February 1, 2022 | February 27, 2026 |
| NCT05223829 | Recruiting | Phase 1 | Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder | August 1, 2023 | April 30, 2024 |
| NCT06139224 | Recruiting | N/A | Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection | March 6, 2024 | September 2025 |
| NCT05305404 | Recruiting | Early Phase 1 | Dexamethasone to Target Stress and Immune System Mechanisms Underlying Alcohol Craving | March 11, 2022 | June 30, 2024 |
| NCT05338151 | Recruiting | N/A | Promoting Alcohol Treatment Engagement Post-hospitalization | September 13, 2022 | December 2026 |
| NCT06143059 | Recruiting | Phase 3 | The Effects of Sex Hormones and Alcohol on Sleep | January 8, 2024 | November 1, 2028 |
| NCT03265808 | Recruiting | Phase 1/Phase 2 | Allogeneic Human Mesenchymal Stem Cell Infusion vs Placebo in Alcohol Use Disorder and Major Depression. | March 18, 2018 | April 2025 |
| NCT05365347 | Recruiting | N/A | Piloting of an Intervention to Reduce Problematic Alcohol Use in Early Phase Psychosis Patients | December 1, 2022 | December 30, 2024 |
| NCT05372029 | Recruiting | N/A | AAT for Alcohol Use Disorder in Veterans | February 3, 2023 | April 3, 2026 |
| NCT05389930 | Recruiting | Phase 2 | Cannabis' Impact on Alcohol Consumption | March 16, 2023 | March 31, 2027 |
| NCT05416229 | Recruiting | Phase 2 | Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder | September 1, 2023 | November 2025 |
| NCT05421065 | Recruiting | Phase 2 | Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder | February 2, 2024 | February 2025 |
| NCT06402240 | Recruiting | N/A | The Pocket Skills Adjunct Project | January 1, 2024 | December 31, 2024 |
| NCT03230006 | Recruiting | N/A | Transdiagnostic CBT for Comorbid Alcohol Use and Anxiety Disorders | March 1, 2018 | August 31, 2023 |
| NCT05479890 | Recruiting | N/A | ClientBot: A Conversational Agent That Supports Skills Practice and Feedback for Motivational Interviewing | January 31, 2023 | August 31, 2024 |
| NCT03191266 | Recruiting | N/A | Transcranial Magnetic Stimulation for the Treatment of Veterans With Alcohol Use Disorders | April 15, 2018 | September 30, 2024 |
| NCT06403332 | Recruiting | N/A | Study of the Drivers of Late Diagnosis of Alcohol Related Diseases, Alone or in Combination With Metabolic Dysfunconal Associated Fatty Liver Disease, Implementation and Evaluation of Itnerventions to Reduce Its Burden. | February 2, 2023 | December 6, 2024 |
| NCT05548452 | Recruiting | Phase 1/Phase 2 | Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease | November 21, 2022 | December 2026 |
| NCT05564663 | Recruiting | N/A | Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes | October 6, 2023 | May 31, 2025 |
| NCT02037867 | Recruiting | Nottingham Community Liver Biomarkers Cohort | May 2013 | May 2033 | |
| NCT05579210 | Recruiting | N/A | Online Relapse Prevention Therapy for Patients With Alcohol Use Disorder | October 1, 2022 | April 23, 2024 |
| NCT05594238 | Recruiting | N/A | Leveraging Virtual Care Strategies to Improve Access and Treatment for Individuals With Alcohol Use Disorders | August 7, 2023 | September 10, 2026 |
| NCT05607290 | Recruiting | N/A | Clinical Course of Alcohol Use Disorder Recovery | May 9, 2023 | August 31, 2027 |
| NCT05613608 | Recruiting | Phase 2/Phase 3 | Alcohol Use Disorder and Cannabidiol | April 30, 2023 | April 2027 |
| NCT05619185 | Recruiting | N/A | A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners | January 9, 2024 | October 27, 2027 |
| NCT06190236 | Recruiting | N/A | Integration of Neurofunctional Phenotyping Into Investigation of CBT4CBT for AUD | April 10, 2024 | December 2024 |
| NCT05630118 | Recruiting | N/A | Online Insomnia Intervention to Reduce Alcohol Use | January 24, 2023 | December 31, 2024 |
| NCT05631366 | Recruiting | N/A | Spaced Versus Massed Alcohol Avoidance Task | October 8, 2021 | August 1, 2025 |
| NCT05636033 | Recruiting | Semantic Networks in Alcohol Use Disorder Patients: Exploratory Study | April 19, 2023 | July 2025 | |
| NCT05641389 | Recruiting | Improving Remote Breathalyzer Procedures Used by Clinicians and Researchers to Remotely Monitor Alcohol Use | August 1, 2022 | July 31, 2024 | |
| NCT05646303 | Recruiting | Phase 2 | Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD) | May 2, 2022 | October 2024 |
| NCT05656534 | Recruiting | Early Phase 1 | Orexin Receptor Antagonists as Modulators of Threat Sensitivity in Individuals With Alcohol Use Disorder | November 29, 2022 | December 30, 2024 |
| NCT05665179 | Recruiting | N/A | Removing Barriers: Community Partnering for Innovative Solutions to the Opioid Crisis | December 23, 2021 | July 31, 2024 |
| NCT05674409 | Recruiting | N/A | Brief Family Involved Treatment Telehealth | March 13, 2023 | March 1, 2029 |
| NCT05674929 | Recruiting | Phase 2 | An Open-Label, Single Dose Study in Patients With Alcohol Use Disorder | May 30, 2023 | October 2024 |
| NCT05675553 | Recruiting | N/A | The Efficacy of Robot-Assisted Intelligent Rehabilitation Treatment in Patients With AUD | June 15, 2022 | March 31, 2024 |
| NCT05677321 | Recruiting | Individual Variations of Taste and Smell Perception in Alcohol Use Disorder (AUD) | January 9, 2024 | December 31, 2027 | |
| NCT05684094 | Recruiting | N/A | Mechanisms of Risky Alcohol Use in Young Adults: Linking Sleep to Reward- and Stress-Related Brain Function | September 7, 2023 | February 28, 2027 |
| NCT05692271 | Recruiting | Phase 2 | Testing a Novel Therapeutic Strategy for Comorbid Post-Traumatic Stress Disorder and Alcohol Use Disorder | July 15, 2023 | February 2025 |
| NCT05709353 | Recruiting | Phase 2 | MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder | September 19, 2023 | May 2026 |
| NCT05722483 | Recruiting | N/A | Intensive Virtual Treatment With Remote Abstinence Monitoring for Alcohol Use Disorder | January 30, 2023 | December 31, 2024 |
| NCT05729243 | Recruiting | Phase 4 | Cytisine for Smoking Cessation | February 8, 2023 | June 2024 |
| NCT05732207 | Recruiting | N/A | Cerebellar Involvement in Alcohol Use Disorder (AUD) | October 12, 2023 | September 2027 |
| NCT05747703 | Recruiting | N/A | Telehealth Treatment for Alcohol Use Disorder | January 31, 2024 | September 2025 |
| NCT05748639 | Recruiting | Phase 3 | RCT of an Integrated Digital Intervention for Alcohol Use Disorder | January 1, 2023 | October 31, 2024 |
| NCT05778734 | Recruiting | N/A | StuDy AimED at Increasing AlCohol AbsTinEnce | July 30, 2023 | May 31, 2028 |
| NCT05781009 | Recruiting | Phase 2 | Pregnenolone for the Treatment of Alcohol Use Disorder | January 8, 2024 | July 31, 2028 |
| NCT05786157 | Recruiting | N/A | Advancing Couple and Family Alcohol Treatment Through Patient-Oriented Research and Mentorship | March 1, 2024 | October 1, 2029 |
| NCT05786872 | Recruiting | N/A | Efficacy and Safety of Dual-target DBS for Treatment-resistant Alcohol Use Disorder | July 5, 2023 | December 31, 2024 |
| NCT06199076 | Recruiting | Phase 2 | Experimental Study on Alcohol Use and Behavior in Young Adults | October 17, 2023 | January 2025 |
| NCT05807139 | Recruiting | Phase 1 | Spironolactone in Alcohol Use Disorder (SAUD) | July 13, 2023 | September 7, 2024 |
| NCT06211959 | Recruiting | N/A | Evaluating the Effectiveness of Implementation Intentions to Strengthen Approach-avoidance Training | January 2, 2021 | July 1, 2024 |
| NCT06319222 | Recruiting | N/A | Implementation of a Digital Clinic for Alcohol-associated Liver Disease and Alcohol Use Disorder (DALC) | March 12, 2024 | April 2025 |
| NCT05827822 | Recruiting | N/A | Effectiveness of a WeChat-based Alcohol Consumption Intervention Mini-program ("Sober Time ACT") in China | March 9, 2023 | December 2023 |
| NCT06434818 | Recruiting | Phase 2 | Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders | July 7, 2023 | June 30, 2025 |
| NCT06249386 | Recruiting | N/A | Adapting and Piloting Behavioral Activation for Veterans With Alcohol Use Disorder and Posttraumatic Stress Disorder | May 30, 2024 | November 2025 |
| NCT05838274 | Recruiting | N/A | Acute Alcohol Response In Bipolar Disorder: a Longitudinal Alcohol Administration/fMRI Study | July 11, 2023 | March 31, 2028 |
| NCT05843435 | Recruiting | Brain Connectivity Between Networks Implied in Inhibition and Cue-reactivity in Alcohol Use Disorder | May 1, 2024 | December 2024 | |
| NCT02231840 | Recruiting | NIAAA Natural History Protocol | January 21, 2015 | December 31, 2044 | |
| NCT04322305 | Suspended | Phase 2 | Pregabalin Trial for the Treatment of Alcohol Use Disorder | January 11, 2021 | September 30, 2024 |
| NCT03897062 | Terminated | Phase 2 | Suvorexant in the Management Comorbid Sleep Disorder and Alcohol Dependence | August 26, 2019 | July 31, 2022 |
| NCT03047577 | Terminated | N/A | Brief Intervention for ICU Patients With Alcohol Use Disorders | March 30, 2017 | October 31, 2022 |
| NCT03018704 | Terminated | Phase 4 | Topiramate Treatment of Alcohol Use Disorders in African Americans | August 1, 2017 | December 31, 2021 |
| NCT06095817 | Terminated | N/A | Project VALOR: Veteran Stress and Wellbeing | June 1, 2023 | October 6, 2023 |
| NCT03291431 | Terminated | N/A | Intermittent Theta Burst for the Treatment of Alcohol Use Disorders in Veterans | December 1, 2017 | July 30, 2022 |
| NCT05312008 | Terminated | Phase 2 | Does Oxytocin Alter Tolerance to or Motivation for Alcohol | January 16, 2022 | December 21, 2023 |
| NCT04404712 | Terminated | Early Phase 1 | FAAH Availability in Psychiatric Disorders: A PET Study | September 23, 2020 | June 30, 2021 |
| NCT04971681 | Terminated | N/A | Frontal-Striatal Reward Circuit Neuromodulation and Alcohol Self-Administration | October 8, 2021 | June 2, 2022 |
| NCT04094584 | Terminated | Phase 4 | Emergency Department Initiated Extended-Release Naltrexone and Case Management for the Treatment of Alcohol Use Disorder | August 14, 2020 | May 1, 2022 |
| NCT04396847 | Terminated | Phase 2 | Laboratory Screening of Lorcaserin for Alcohol Use Disorder | October 25, 2019 | February 26, 2020 |
| NCT04287790 | Terminated | Promoting Medications for Alcohol Use Disorder on the General Medicine Service | January 1, 2020 | February 1, 2021 | |
| NCT03966885 | Terminated | N/A | Zambia Common Elements Treatment Approach Pilot Study | June 24, 2019 | March 17, 2020 |
| NCT01408641 | Terminated | N/A | Topiramate for Alcohol Use in Posttraumatic Stress Disorder | September 2012 | August 2013 |
| NCT03645408 | Terminated | Phase 1 | The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers | May 2, 2019 | July 1, 2021 |
| NCT03970109 | Terminated | Phase 2 | HLAB-002 of ANS-6637 for Alcohol Use Disorder | October 8, 2019 | May 22, 2020 |
| NCT02368431 | Terminated | Phase 3 | Effectiveness of Zonisamide in Alcohol Dependent Veterans | March 1, 2015 | October 1, 2018 |
| NCT02510508 | Terminated | N/A | Group Version of CRAFT Compared to Self-Directed CRAFT Delivery and Non-intervention: a Three-armed RCT | August 2015 | February 2017 |
| NCT03539432 | Terminated | Phase 2 | Exploration of Gemfibrozil as a Treatment for AUD | May 16, 2018 | December 30, 2018 |
| NCT03860753 | Terminated | Phase 1/Phase 2 | Effects of Pioglitazone on Stress Reactivity and Alcohol Craving (Pilot) | March 1, 2019 | August 23, 2019 |
| NCT04596267 | Terminated | Phase 1 | Pitolisant Effects on Alcohol Self-Administration in Heavy Drinkers | September 13, 2021 | February 3, 2023 |
| NCT05400135 | Unknown status | N/A | Qungasvik (Toolbox): Prevention of Alcohol/Suicide Risk in Alaska Native Youth | March 16, 2017 | March 2023 |
| NCT03902171 | Unknown status | Soberlink Within In-Home Addiction Treatment Program | April 2, 2019 | September 5, 2020 | |
| NCT03932149 | Unknown status | N/A | The Effect of Intermittent Theta Burst Stimulation (iTBS) in Patients With Alcohol Use Disorder | December 6, 2019 | March 2021 |
| NCT04345302 | Unknown status | N/A | Brief Motivational Therapy Versus Usual Care for Alcohol Use Disorders in Primary Care. | November 1, 2021 | November 2022 |
| NCT03919695 | Unknown status | N/A | Development of an Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement Among Fisherfolk in Uganda | December 7, 2020 | July 2022 |
| NCT03235531 | Unknown status | Phase 4 | Assessment of Valproate on Ethanol Withdrawal | July 11, 2017 | January 1, 2020 |
| NCT03878225 | Unknown status | N/A | Does a Ketogenic Dietary Supplement Reduce Alcohol Withdrawal Symptoms in Humans? | June 15, 2020 | March 31, 2022 |
| NCT04381533 | Unknown status | N/A | Internet-based A-CRA for Young Adults With Problematic Alcohol Use | February 11, 2022 | September 2022 |
| NCT03150550 | Unknown status | N/A | Study of Mindfulness Practice Efficacy in Alcoholic Relapse Prevention | January 21, 2017 | September 2018 |
| NCT03848000 | Unknown status | N/A | Examination of Whether an Exercise Programme Reduces Alcohol Consumption Among Alcohol-Dependent Adults | January 21, 2019 | October 2022 |
| NCT03069118 | Unknown status | N/A | 90-Day Online Substance Use Program | February 1, 2017 | December 1, 2017 |
| NCT02752503 | Unknown status | N/A | Nalmefene in Alcohol Dependence and Borderline Personality Disorder | March 2015 | |
| NCT02596763 | Unknown status | Phase 4 | Phone-based Safety Monitoring of Baclofen Prescriptions for Alcohol Use Disorder | December 2015 | January 2022 |
| NCT03758053 | Unknown status | Adverse Childhood Experiences in Substance-related Disorders | December 15, 2018 | August 31, 2021 | |
| NCT04999371 | Unknown status | N/A | Effects of Training Combined With a Small Financial Incentive on Reducing Alcohol Consumption | July 29, 2021 | July 31, 2022 |
| NCT03952429 | Unknown status | N/A | A Smartphone Based Intervention for the Prevention of Relapse in Alcohol Dependence | May 23, 2019 | July 31, 2022 |
| NCT04232800 | Unknown status | Phase 2 | Riboflavin for Glutamate Reduction in Alcohol Withdrawal | December 1, 2021 | October 25, 2022 |
| NCT02544581 | Unknown status | Preliminary Analysis of the Soberlink Alcohol Breath Analyzer System's (SABA) Clinical Utility During Aftercare | September 2015 | November 2015 | |
| NCT04206930 | Unknown status | N/A | Impact of Art Therapy on Alexithymia in People With Alcohol Use Disorder | December 13, 2019 | December 13, 2022 |
| NCT04198311 | Unknown status | N/A | Sleep Treatment for Addiction Recovery | August 26, 2020 | December 31, 2022 |
| NCT04283305 | Unknown status | N/A | Virtual Reality Alcohol Avoidance Training | March 1, 2020 | July 31, 2021 |
| NCT04158778 | Unknown status | Phase 1 | Bristol Imperial MDMA in Alcoholism Study | April 18, 2018 | June 12, 2020 |
| NCT03396887 | Unknown status | N/A | The Effectiveness of a Smartphone Application in the Treatment of Alcohol Use Disorder | May 1, 2017 | September 30, 2018 |
| NCT04135599 | Unknown status | N/A | A Study of the Effectiveness of Direct Current Stimulation for Alcohol Use Disorders | October 31, 2019 | April 30, 2020 |
| NCT03293017 | Unknown status | Phase 4 | Baclofen in Managing Acute Alcohol Withdrawal | February 1, 2016 | February 1, 2022 |
| NCT03281057 | Unknown status | N/A | Community Reinforcement and Family Training (CRAFT) | January 1, 2018 | December 31, 2022 |
| NCT05337488 | Unknown status | Contributing Factors of Solitary Drinking Among Adolescents and Young Adults | August 2022 | September 2022 | |
| NCT03865615 | Withdrawn | Phase 2 | Oxytocin on Approach Bias and Craving | November 1, 2023 | April 20, 2024 |
| NCT03398252 | Withdrawn | Phase 1 | Targeting Stress-Induced Alcohol Relapse Risk With Doxazosin XL | May 12, 2022 | October 1, 2023 |
| NCT03244592 | Withdrawn | Phase 1/Phase 2 | Minocycline for Alcohol Use Disorder | January 15, 2018 | March 1, 2018 |
| NCT05756114 | Withdrawn | N/A | Self Management and Recovery Training (SMART) Recovery Study | April 2023 | April 2025 |
| NCT04157114 | Withdrawn | Phase 2 | MAP4343 Treatment for Alcohol Use Disorder | December 2021 | December 2022 |
| NCT04070508 | Withdrawn | Early Detection of Alcoholic Liver Disease | April 1, 2023 | November 3, 2025 | |
| NCT04579068 | Withdrawn | N/A | Decreasing Alcohol Use Through Student Peer Leaders | August 21, 2021 | October 20, 2026 |
| NCT05661669 | Withdrawn | Phase 2 | Ketamine for the Treatment for Alcohol Use Disorder in the ED | October 25, 2023 | June 6, 2024 |
| NCT03376139 | Withdrawn | Phase 2 | Zonisamide Outpatient Study | March 1, 2019 | August 31, 2019 |
| NCT04464148 | Withdrawn | Phase 1 | Feasibility Trial of Pregnenolone for Posttraumatic Stress Disorder and Alcohol Use Disorder | December 2021 | December 2021 |
| NCT04311294 | Withdrawn | Phase 2 | Development of a Selective ALDH2 Inhibitor to Treat AUD | April 2020 | March 2022 |
| NCT05087771 | Withdrawn | Phase 4 | In Hospital IM Naltrexone: A Pilot Study | March 2022 | June 2023 |
| NCT04159909 | Withdrawn | N/A | Using Transcutaneous Auricular Vagus Nerve Stimulation to Treat Acute Alcohol Withdrawal | January 31, 2024 | January 30, 2025 |
| NCT04223011 | Withdrawn | N/A | Initiating Substance Use Disorder Treatment for Hospitalized Alcohol Use Disorder Patients | March 1, 2020 | December 2020 |
| NCT03636555 | Withdrawn | Phase 2 | Oxytocin Treatment for Alcohol Use Disorders | October 2019 | September 2022 |
| NCT04964843 | Withdrawn | Phase 2 | A Study of NAC for AUD | April 2023 | January 2025 |
| NCT03904849 | Withdrawn | Phase 1/Phase 2 | Cannabidiol for Alcohol Use Disorder | October 1, 2019 | April 30, 2020 |
| NCT03582150 | Withdrawn | N/A | Ambulatory Alcohol Detoxification With Remote Monitoring | July 3, 2018 | December 2021 |
- Disase is a (Disease Ontology)
- DOID:302
- Cross Reference ID (Disease Ontology)
- ICD10CM:F10.1
- Cross Reference ID (Disease Ontology)
- ICD9CM:305.0
- Cross Reference ID (Disease Ontology)
- MESH:D000437
- Cross Reference ID (Disease Ontology)
- NCI:C20701
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:15167005
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0085762
- Exact Synonym (Disease Ontology)
- alcohol abuse
- Exact Synonym (Disease Ontology)
- Ethanol abuse